MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Clinical Cancer Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,205 results · 1 filter active ·
Results by year
20042025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,205 works in the cohort · of 4,299,418page 11 of 45

Labels cover 5 of 2,205 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,205 of 2,205 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Alternate Endpoints for Screening Phase II Studies
Neesha C. Dhani, Dongsheng Tu, Daniel J. Sargent, Lesley Seymour, Malcolm J. Moore
2009· review· en· Clinical Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
85
citations
afffundunlabeled
Liposomal Irinotecan
Corrie Lynn Messerer, Euan C. Ramsay, Dawn Waterhouse, Rebecca Ng, Eva-Maria Simms, Natashia Harasym +3 more
2004· article· en· Clinical Cancer Research· Materials Science
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
82
citations
afffundunlabeled
Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction
Corinna Warburton, Wieslawa H. Dragowska, Karen A. Gelmon, Stephen Chia, Hong Yan, Dana Masin +3 more
2004· article· en· Clinical Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
81
citations
affunlabeled
Rapid Diagnosis of Medulloblastoma Molecular Subgroups
Ed C. Schwalbe, Janet C. Lindsey, Debbie Straughton, Twala L. Hogg, Michael Cole, Hisham Megahed +7 more
2011· article· en· Clinical Cancer Research· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
80
citations
← previousnext →

How this was built: Screen · Findings · About